Raymond L. H. Lam

Statistics

Publications

Citations

503

H-Index

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Research Triangle Park Foundation

Rady Children's Hospital-San Diego

Hospital General San Juan de Dios

Indiana University School of Medicine

Raymond L. H. Lam is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in diabetes mellitus, pharmacology, and diabetes management.

Publications per year

1991–2023

Publications

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease

Manuel Romero‐Gómez, Eric Lawitz, R. Ravi Shankar et al. · Journal of Hepatology · 2023 · 192 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Statistical Design of Pools Using Optimal Coverage and Minimal Collision

Katja Sabine Remlinger, Jacqueline M. Hughes‐Oliver, S. Stanley Young et al. · Technometrics · 2006 · 57 citations

Pharmacy, Medicinal Chemistry, Combinatorial Chemistry +16

A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study

Russell Scott, Jerry D. Morgan, Zachary Zimmer et al. · Diabetes Obesity and Metabolism · 2018 · 56 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Uniform Coverage Designs for Molecule Selection

Raymond L. H. Lam, William J. Welch, S. Stanley Young · Technometrics · 2002 · 37 citations

Pharmacy, Medicinal Chemistry, Drug Design +13

A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes

R. Ravi Shankar, Philip Zeitler, Asma Deeb et al. · Pediatric Diabetes · 2021 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 13